LIEBERBURG IVAN M
Insider CIK 1266427 · ADMS Director · MRTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 468,639 | $13.00 | $6.09M | 332,809 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 128,805 | $5.60 | $721.3K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 13,996 | $5.60 | $78.4K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 4 | $181.00 | $724 | 2,363,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 13,996 | — | $0 | 267,334 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 363,000 | $181.15 | $65.76M | 2,000,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 1 | $181.00 | $181 | 267,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 597,444 | — | $0 | 2,363,004 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 37,000 | $181.15 | $6.70M | 230,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 37,051 | $5.60 | $207.5K | 13,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 362,952 | $5.60 | $2.03M | 128,805 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 37,050 | $202.00 | $7.48M | 216,288 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 2 | $219.97 | $440 | 1,765,560 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 362,952 | — | $0 | 1,765,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 362,950 | $202.00 | $73.32M | 1,404,610 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 1 | $219.97 | $220 | 253,338 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 37,051 | — | $0 | 253,339 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2020-06-03 | 2020-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2020-06-03 | 2020-06-05 | 5,000 | — | $0 | 53,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2019-06-05 | 2019-06-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2018-06-06 | 2018-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 189,780 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 78,186 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 78,186 | $7.86 | $614.5K | 513,630 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 189,780 | $7.86 | $1.49M | 1,227,774 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 51,047 | $5.60 | $285.9K | 51,047 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 2,341,786 | $5.60 | $13.11M | 2,341,786 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 280,059 | $5.60 | $1.57M | 1,037,994 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 6,104 | $5.60 | $34.2K | 435,444 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2016-06-03 | 2016-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-12-07 | 2015-12-09 | 3,000 | $16.23 | $48.7K | 48,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-11-02 | 2015-11-04 | 3,000 | $15.00 | $45.0K | 51,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-10-05 | 2015-10-07 | 3,000 | $16.75 | $50.3K | 54,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-09-08 | 2015-09-10 | 3,000 | $19.13 | $57.4K | 57,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-08-03 | 2015-08-05 | 3,000 | $24.51 | $73.5K | 60,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-07-06 | 2015-07-08 | 3,000 | $25.91 | $77.7K | 63,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-06-01 | 2015-06-03 | 3,000 | $17.93 | $53.8K | 66,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2015-05-14 | 2015-05-18 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-04 | 2015-05-06 | 3,000 | $16.82 | $50.5K | 69,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-06 | 2015-04-07 | 3,000 | $17.44 | $52.3K | 72,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-02 | 2015-03-04 | 3,000 | $16.97 | $50.9K | 75,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-02-02 | 2015-02-03 | 3,000 | $16.77 | $50.3K | 78,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-01-05 | 2015-01-07 | 3,000 | $17.59 | $52.8K | 81,000 | SEC↗ |